The Same AI That Helps Patients Is Being Used to Attack Them, Hospital Exec Says
As hospitals increasingly use AI to improve patient care, the same technology is being used…
The Same AI That Helps Patients Is Being Used to Attack Them, Hospital Exec Says
As hospitals increasingly use AI to improve patient care, the same technology is being used by hackers and nation-states to launch faster, more sophisticated attacks. Karen Habercoss, chief information security and privacy officer at the University of Chicago Medicine, explained how her health system is building a governance structure to manage that risk. The post…
How Should Clinical AI Be Paid For? 3 Takeaways
A new report from the Peterson Health Technology Institute argues that today’s healthcare payment models are ill-suited for clinical AI and could drive up costs. The post How Should Clinical AI Be Paid For? 3 Takeaways appeared first on MedCity News.
Expecting Massive Test Growth in Cancer & More, Tempus AI Strikes $1.5B Deal to Buy Personalis
Personalis’s liquid biopsy is part of a growing market for minimal residual disease assays, tests that look for any remaining cancer cells after the initial treatment. Tempus AI has been the commercial partner on this Personalis test since 2023. The post Expecting Massive Test Growth in Cancer & More, Tempus AI Strikes $1.5B Deal to…
The AI Tension in Healthcare: Patent Strategy, FDA Reality, and HIPAA Constraints
These three legal regimes are pulling in different directions, and the developers that navigate them well will be the ones that plan for all three from the start. The post The AI Tension in Healthcare: Patent Strategy, FDA Reality, and HIPAA Constraints appeared first on MedCity News.
For Millions in Rural America, Medicine Is Still Far Away
Rural Health Transformation Program funding gives states broad flexibility and may help address longstanding access gaps. The post For Millions in Rural America, Medicine Is Still Far Away appeared first on MedCity News.
Pregnant Woman’s Roadside Death Triggers Push To Reopen Mississippi Delta Hospital
BELZONI, Miss. — Harmony Ball-Stribling’s path to pregnancy had been turbulent, from an endometriosis diagnosis to an arduous in vitro fertilization process and sky-high blood pressure. But as her due date approached in the summer of 2021, her health improved and those storm clouds seemed to scatter. “It was just too perfect,” said her mother,…
Doctors ‘Cringe’ at Possibility of Documenting Which Medicaid Enrollees Too Sick To Work
Alice Thornton has spent more than two decades treating people living with HIV in Lexington, Kentucky. Her team tends to “cringe” anytime they hear about patients having to fill out lots of paperwork, like when applying for Social Security Disability payments, because it can be a difficult, burdensome process. Thornton tries to support her patients,…
Violence Repeatedly Erupts at Dementia Care Facilities Despite Warnings, Inspections Show
Sam Ato Timaloa, a paroled sex offender who also served time for attempted murder, had dementia and an acute intolerance of noise — especially from roommates at Sunrise Post Acute, a nursing home in Banning, California. Over four months in 2025, a state investigative report found, Sunrise switched Timaloa’s room eight times, the last into…
Women’s Oncology Market Could Reach $110B in 2030, but Gaps Remain
A new PwC report says the women’s oncology market could reach $110 billion by 2030, though funding and care gaps remain. The post Women’s Oncology Market Could Reach $110B in 2030, but Gaps Remain appeared first on MedCity News.
Merck Pill Becomes First Oral Option in Growing Class of Cholesterol-Lowering Drugs
Merck’s Lipfendra is the first FDA-approved pill in the class of cholesterol-lowering drugs called PCSK9 inhibitors. While peptides are typically injected, Lipfendra is a macrocyclic peptide designed for formulation as an oral drug. The post Merck Pill Becomes First Oral Option in Growing Class of Cholesterol-Lowering Drugs appeared first on MedCity News.
